Small-conductance calcium-activated potassium type 2 channels (SK2, KCa2.2) in human brain by Michael Willis et al.
ORIGINAL ARTICLE
Small-conductance calcium-activated potassium type 2 channels
(SK2, KCa2.2) in human brain
Michael Willis1 • Maria Trieb2 • Irmgard Leitner2 • Georg Wietzorrek2 •
Josef Marksteiner3 • Hans-Gu¨nther Knaus2
Received: 18 February 2016 / Accepted: 20 June 2016 / Published online: 29 June 2016
 The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract SK2 (KCa2.2) channels are voltage-independent
Ca2?-activated K? channels that regulate neuronal
excitability in brain regions important for memory forma-
tion. In this study, we investigated the distribution and
expression of SK2 channels in human brain by Western
blot analysis and immunohistochemistry. Immunoblot
analysis of human brain indicated expression of four dis-
tinct SK2 channel isoforms: the standard, the long and two
short isoforms. Immunohistochemistry in paraffin-embed-
ded post-mortem brain sections was performed in the
hippocampal formation, amygdala and neocortex. In hip-
pocampus, SK2-like immunoreactivity could be detected in
strata oriens and radiatum of area CA1-CA2 and in the
molecular layer. In the amygdala, SK2-like immunoreac-
tivity was highest in the basolateral nuclei, while in neo-
cortex, staining was mainly found enriched in layer V.
Activation of SK2 channels is thought to regulate neuronal
excitability in brain by contributing to the medium after-
hyperpolarization. However, SK2 channels are blocked by
apamin with a sensitivity that suggests heteromeric chan-
nels. The herein first shown expression of SK2 human
isoform b in brain could explain the variability of elec-
trophysiological findings observed with SK2 channels.
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Introduction
SK2 (KCa2.2) channels are voltage-independent Ca2?-
activated K? channels. In central neurons, activation of
these channels modulates neuronal excitability by caus-
ing membrane hyperpolarization (Lin et al. 2008). A
wide range of functions of SK2 channels have been
described in CA1 hippocampal neurons. It appears that
separate populations of SK2 channels in CA1 neurons
occupy discrete subcellular positions where they couple
with different Ca2? sources to serve distinct physiologi-
cal roles (Ngo-Anh et al. 2005). SK2 channels have been
shown to be located in the cell soma, as well as in
presynaptic and postsynaptic compartments. In the
presynaptic compartment of CA1 neurons, opening of
SK2 channels can be associated with the control of
neurotransmitter release (Ballesteros-Merino et al. 2012).
In the postsynaptic membrane of glutamatergic synapses,
activation of SK2 channels modulates synaptic trans-
mission and the induction and expression of synaptic
plasticity (Adelman et al. 2012). These functions are
supported by the co-localization of SK2 channels with
NMDA receptors in dendritic spines of CA1 neurons (Lin
et al. 2008). In this micro-domain, Ca2? entry after
synaptic activation opens SK2 channels, which in turn
limit the amplitude of synaptic potentials and reduce
Ca2? influx through NMDA receptors (Ngo-Anh et al.
2005). Therefore, hippocampal SK2 channels play a
critical role in the formation of new memory (Hammond
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et al. 2006) as well during encoding and consolidation of
contextual fear (Murthy et al. 2015) and drug-induced
plasticity (Fakira et al. 2014). Furthermore, SK2 channels
act neuroprotective in ischemia-induced neuronal cell
death (Allen et al. 2011a), and moreover, activation of
SK2 channels seems to block pathological Ca2? influx
from the extracellular space in the context of glutamate
excitotoxicity and, therefore, promotes neuroprotection
(Dolga and Culmsee 2012).
Four different SK2 channel isoforms have been
described in mouse brain (Sailer et al. 2004; Strassmaier
et al. 2005; Murthy et al. 2008; Chakroborty et al. 2012).
The core protein of the standard isoform of SK2 channels
(SK2-std) has a calculated molecular weight of about
*58 kD (Sailer et al. 2004). The long isoform (SK2-long)
with a molecular weight of *78 kD, differs from the
standard isoform only in the length of the intracellular
N-terminal domain, with additional 207 amino acids at the
N-terminus (Strassmaier et al. 2005). Two short isoforms
have also been described; one resulting from a post-
translational modification of the standard isoform, the
SK2 short splice variant (SK2-ssv), the other isoform is
believed to be a transcript variant termed SK2 human
isoform b (SK2-hib). SK2-ssv displays an apparent
molecular weight of *47 kD, because it is lacking 140
amino acids including transmembrane domains S3, S4 and
S5. This isoform is a result of post-translational splicing
and has been first described in mice (Murthy et al. 2008).
The other short isoform SK2-hib with an expected
molecular weight of*26 kD, differs in the 50 UTR and 50
coding region and initiates translation at a downstream
start codon compared to SK2-std. It is lacking the N-ter-
minal region including transmembrane domains S1–S5.
Expression of SK2-hib has been shown in mouse brain
revealing a band at *29 kD in immunoblots (Chakro-
borty et al. 2012).
Our study establishes the distribution of SK2 channels
on a protein level in human brain for the first time. Pre-
vious quantitative RT-PCR analysis of SK2 expression in
human CNS showed highest expression in hippocampus
and amygdala (Rimini et al. 2000). Therefore, we focused
our immunoblotting and immunohistological approaches
on the expression profile of SK2 channels in these partic-
ular brain regions, namely the hippocampus, the amygdala
and the neocortex. Our findings present evidence that all
known SK2 channel isoforms are indeed expressed in
human brain and reflect findings for murine brain. More-
over, it represents the first direct demonstration that SK2




Human SK2 channels are encoded by the KCNN2 gene.
Alternate splicing of this gene results in two transcript
variants, SK2 human isoform a (NCBI Reference
Sequence: NP_067627.2) and SK2 human isoform b (NCBI
Reference Sequence: NP_001265133.1). The SK2 long
isoform (NCBI Reference Sequence: XP_011541691.1) is
generated from an upstream promoter.
Antibodies
A large panel of anti-SK2 antibodies were raised in our
laboratory. These antibodies together with commercially
available antibodies from Abcam (ab85401 and ab48817),
Thermo Fisher Scientific Pierce (PA5-19205) and Alomone
(APC-028) were screened in immunoblot and immuno-
histological analysis.
Only two individual antibodies turned out to be suit-
able for human tissues. The N-terminal SK2 antibody used
in our study (Anti-NSK2) was produced in our laboratory
against the amino acid sequence 19–37 (ASRRNL-
HEMDSEAQPLQPP). This sequence is highly conserved
within different species and, therefore, could be used for
experiments with human and mouse tissue. Mouse and rat
SK2 channels possess a homologous amino acid sequence
in this region, while the human SK2 sequence differs only
in a single amino acid at position 19. The antibody directed
against the carboxy-terminus of the SK2 channel (Anti-
CSK2) recognizes the amino acid sequence 421–469 of
human SK2 channel (Anti-KCNN2, ab85401 from Abcam)
(Chakroborty et al. 2012). Mouse and human SK2 channels
have homologous amino acid sequences in this region.
Human brain tissue
Brain samples used in immunohistochemistry were
obtained at routine autopsy at a post-mortem interval of
18 ± 3.5 h from eight adult humans (four males and four
females; age averaged 70 ± 8.6 years), with no known
neurological or psychiatric disease. Cause of death was
myocardial infarction, aspiration pneumonia, pulmonary
embolism, liver cancer, rupture of the aorta and traffic
accident. Hospital and other medical records confirmed that
these subjects had normal intellectual function until the
time of their deaths. Three of the histologically proven
normal subjects displayed very few neocortical plaques,
but no neocortical tangles. In three cases, a few plaques
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were detected in the subiculum. In one case out of these
three, plaques were also detected in the CA1 area. The
brain sample for the membrane preparations was dissected
from a 56-year-old male who died from prostate cancer;
tissue was obtained at routine autopsy 8 h after death. All
procedures performed were in accordance with the ethical
standards of the institutional research committee and with
the 1964 Helsinki declaration and its later amendments or
comparable ethical standards. All regulations mandated by
the Austrian Ministry of Health were honored.
Membrane preparations
For immunoblotting experiments, membrane preparations
of whole mouse brain from 6-month-old C57BL/6 mice
(n = 2) were performed as described earlier (Sailer et al.
2002, 2004). All procedures used in this study that
involved animals were carried out in accordance with the
Austrian regulations governing the use of animals in sci-
entific research. Preparations of human brain synaptic
plasma membrane vesicles of the occipital region were
performed using the identical protocol and stored at
-80 C. All preparations were performed in the presence
of a protease inhibitor cocktail. Parallel Western blots
using antibodies against various Kv1 channels as well as
the BK channel alpha subunit were used. These additional
controls were chosen as these structurally related potas-
sium channels are known to be prone to spontaneous pro-
teolysis, which is always a concern when using human
post-mortem tissues for biochemical investigations. These
experiments did not yield any evidence for time-dependent
proteolysis or sample decay (data not shown).
Immunoblot analysis
Immunoblot analyses were performed as described earlier
(Sailer et al. 2002, 2004) with some minor modifications.
Whole brain preparations of mouse synaptic vesicles and
preparations of human brain synaptic plasma membrane
vesicles of the occipital region were used in immunoblot
analysis. Samples of 10 lg protein per lane were separated
by 10 % SDS-PAGE and transferred to polyvinylidene
difluoride (PVDF) membranes. The membranes were
blocked with 3 % BSA and 0.05 % (w/v) Tween 20 dis-
solved in phosphate-buffered saline (PBS) for 120 min at
22 C. Membranes were incubated with primary antibodies
(antibody dilution 1 lg/ml for Anti-CSK2 and 1 lg/ml for
Anti-NSK2) dissolved in 1 % BSA and 0.05 % (w/v)
Tween 20 PBS for 16 h at 4 C. Membranes were washed
for 30 min in PBS 0.05 % (w/v) Tween 20. Secondary
antibodies [anti-rabbit IgG (whole molecule) peroxidase
conjugate A-0545 from Sigma-Aldrich] diluted 1:80,000
were incubated for 1 h at 22 C. Blots were washed for
45 min in PBS 0.05 % (w/v) Tween 20 and for 10 min in
PBS. For visualization, membranes were transferred to
ECL plus Western Blotting Detection System from
Amersham Biosciences (RPN2132) (5 min) and exposed to
an X-ray film.
Immunohistopathology
Paraformaldehyde was removed by treatment in butyl
acetate. Sections were rehydrated in an ethanol series fol-
lowed by immersion in 25 mM Tris-buffered saline (TBS).
Endogenous peroxidase was blocked by addition of 20 %
methanol, 0.9 % H2O2 in 25 mM TBS for 20 min, fol-
lowed by antigen retrieval by microwave treatment for
15 min in sodium citrate buffer. Thereafter, sections were
incubated in blocking buffer (10 % NGS 0.1 % Triton
X-100 TBS) for 90 min. Sections were incubated with
antibodies against SK2 channels (antibody dilution 3 lg/ml
for Anti-CSK2 and 3 lg/ml for Anti-NSK2) diluted in 3 %
NGS-T-TBS for 16 h at room temperature. Sections were
washed in T-TBS and subsequently incubated with a
streptavidin–horseradish peroxidase-conjugated goat anti-
rabbit antibody (P0448 from DAKO) diluted 1:300 in
T-TBS for 150 min. Sections were washed in 50 mM TBS,
pH 8 before antigen–antibody complexes were visualized
using 0.63 mM 3,30-diaminobenzidine (DAB), 10 mM
nickel ammonium sulfate, and 0.002 % H2O2 in 50 mM
TBS, pH 8. Stained sections were dehydrated in a series of
ethanols, cleared in butyl acetate, and cover-slipped with
Roti-Histokitt (Carl Roth, Germany). Stained tissue sec-
tions were visualized using a Zeiss Axioplan 2 imaging
microscope. All images were photographed with an Axio
Cam digital camera.
Results
Characterization of the antibodies
A large panel of anti-SK2 antibodies were initially char-
acterized in immunoblot analysis using mouse and human
tissue. Negative controls were performed by blocking the
antibody reaction with antigenic peptide or by using the
respective preimmune sera. Only a single antibody directed
against the amino-terminus (Anti-NSK2) and a single
antibody directed against the carboxy-terminus (Anti-
CSK2) fulfilled the criteria of specificity and were used in
the current work (see ‘‘Materials and methods’’).
Immunoblot analysis of SK2 channels
Immunoblot analysis with Anti-CSK2 in human brain tis-
sue revealed a band at an apparent molecular weight above
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*52 kD corresponding to the standard SK2 channel iso-
form. Two additional bands of *40 and *26 kD might
reflect shorter isoforms, while an additional, however, very
weakly stained band at*80 kD could also be detected. In
mouse synaptic vesicle preparations (derived from whole
brain), bands with a very similar apparent mobility could
also be detected (Fig. 1a, Anti-CSK2). The observed
molecular weight values for SK2 channels are in good
agreement with the deduced molecular weights (see
‘‘Discussion’’). For the C-terminal antibody, no peptide or
preimmune serum was available; therefore, no controls can
be shown.
Now characterizing the N-terminal, Anti-NSK2 anti-
body in mouse and human brain membranes yielded a
different staining pattern. While bands with an apparent
molecular weight of *80 kD and the *52 kD reflecting
the long and the standard isoform were recognized by this
antibody for both species, the band at *40 kD could just
be recognized in mouse brain (Fig. 1a, Anti-NSK2). The
band at apparent molecular weight of *26 kD was not
recognized by this antibody, which is in accordance with
the fact that this isoform lacks the SK2 N-terminus and,
therefore, also the recognition site as outlined in the model
in Fig. 1b. The immunostaining signal was not present
when using the respective preimmune sera in human brain
(data not shown); the signal was blocked by pre-incubation
with the corresponding peptide in mouse and human brain
(Fig. 1a, Anti-NSK2PB).
Immunohistochemistry of SK2 channels in human
brain
Immunohistochemistry with Anti-NSK2 in human post-
mortem brain was performed in hippocampus, amygdala
and neocortex. In human hippocampus, laminar SK2-like
immunoreactivity (SK2-LI) was detected in the strata
radiatum and oriens of CA2 and CA1, the subiculum and in
molecular layer (Fig. 2a). In the amygdala, SK2-LI was
mainly detected in the basolateral nuclei (Fig. 2b), while in
the neocortex, SK2-LI was mainly detected in layer V
(Fig. 2c). SK2-LI detected with Anti-NSK2 was blocked
by pre-incubation with the corresponding peptide (Fig. 2a,
inlay).
Subsequently, immunohistochemistry with both Anti-
NSK2 and Anti-CSK2 was performed in adjacent sections
of human brain to detect differences in SK2-LI of these two
antibodies which were previously characterized by Wes-
tern blotting experiments (Fig. 3). In the hippocampus,
both antibodies detected strong SK2-LI in strata radiatum
and oriens close to the pyramidal cell layer (Fig. 3a, b).
Especially in the layer of the proximal dendrites of pyra-
midal cells, SK2-LI was prominently present in stratum
oriens. In stratum pyramidale, neurons displayed only
moderate SK2-LI detected with Anti-NSK2 (Fig. 3f), while
Anti-CSK2 detected prominent immunoreactivity
(Fig. 3e). SK2-LI in pyramidal CA1 neurons was located in
the cell soma and the apical dendrite of the cells (Fig. 3e).
Molecular layer displayed strong SK2-LI, while in granule
cell layer, mainly the cell membrane was SK2
immunopositive (Fig. 3c, d). Granule cells of the dentate
gyrus showed moderate immunoreactivity with Anti-NSK2
(Fig. 3d), while Anti-CSK2 displayed a strong staining
signal (Fig. 3c). In the amygdala, strong SK2-LI was
detected in pyramidal cells with both antibodies (Fig. 3g,
h), while Anti-NSK2 detected a more diffuse signal. In
neocortex, mainly pyramidal cells of layer V were detected
with both Anti-NSK2 and Anti-CSK2 (Fig. 3i, j). In con-
clusion, SK2-LI detected with Anti-NSK2 was more
restricted to laminar structures reflecting immunoreactivity
in dendritic structures, while SK2-LI detected with Anti-
Fig. 1 Western blot of the C-terminal (Anti-CSK2) and the N-ter-
minal (Anti-NSK2) antibody directed against the SK2 peptide (a). A
band corresponding to the standard SK2 channel isoform was detected
at *52 kD with both antibodies in human and mouse brain tissue.
Anti-CSK2 detected three another bands corresponding to two short
isoforms and the long isoform of SK2 in human brain. Anti-NSK2
detected signals corresponding to the standard isoform and the long
isoform, while the signals for short isoforms were missing. Schematic
illustration of Anti-CSK2 and Anti-NSK2 recognition sites (b). hbr
human brain, mbr mouse brain, Anti-CSK2 C-terminal SK2 antibody,
Anti-NSK2 N-terminal SK2 antibody, Anti-NSK2PB peptide block of
Anti-NSK2
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CSK2 was prominent in cellular structures reflecting
immunoreactivity in intracellular compartments.
Discussion
In the present paper, we establish, for the first time, the
distribution profile of SK2 channel protein in human brain.
Specificity of the anti-SK2 channel antibodies was assessed
through immunoblot experiments using membranes
derived from mouse brain synaptosomes, and these data
were compared to human brain tissue.
Immunoblot experiments
In human brain, Anti-CSK2 antibody detected four bands,
which can be explained by the putative expression of four
different SK2 channel isoforms (SK2-std, SK2-long, SK2-
ssv and SK2-hib) in human brain. These four different SK2
channel isoforms have already been described in mouse
brain (Sailer et al. 2004; Strassmaier et al. 2005; Murthy
et al. 2008; Chakroborty et al. 2012). The band at a
molecular weight of*52 kD reflects immunoreactivity for
SK2-std (Bond et al. 2004), which forms functional chan-
nels that modulate neuronal excitability (Weatherall et al.
2011) and plays a critical role in memory formation, fear-
and drug-induced plasticity and neuroprotection (Ham-
mond et al. 2006; Dolga and Culmsee 2012; Fakira et al.
2014; Murthy et al. 2015). Up to now, there was no evi-
dence for a SK2-long isoform in human brain. Immunoblot
analysis with both antibodies revealed a band at a molec-
ular weight of about *80 kD. This could reflect
immunoreactivity for the long isoform (Strassmaier et al.
2005). The long isoform is believed to direct synaptic SK2
channel expression and is important for normal synaptic
signaling, plasticity and learning (Allen et al. 2011b). Our
Western blot experiments with Anti-CSK2 detected two
bands at molecular weights of approximately *40 and
*26 kD. This finding is in accordance with the expression
of two shorter isoforms that are also present in human
brain. With the Anti-NSK2 antibody, staining at the
apparent molecular weight of SK2-ssv and of SK2-hib was
missing. The band at apparent molecular weight of
*40 kD could reflect the expression of SK2-ssv. The
physiological role of SK2-ssv is unclear. In brain sections
from mice, SK2-std and SK2-ssv do not show overlapping
expression pattern. Additional electrophysiological
recordings from transiently expressed SK2-ssv revealed no
functional channel activity or interaction with SK2-std
(Murthy et al. 2008). The band at molecular weight of
*26 kD, which was only recognized by Anti-CSK2, could
reflect immunoreactivity for SK2-hib. Since SK2-hib lacks
the N-terminal sequence which is recognized by Anti-
NSK2, this antibody is not able to recognize this isoform.
Immunohistochemistry
In general, the observed distribution of SK2-LI in human
brain is in accordance with distribution in murine brain.
Rat brain in situ hybridization experiments and Northern
blot analysis detected high SK2 mRNA levels in the hip-
pocampal formation, neocortex and amygdala (Kohler
et al. 1996; Stocker et al. 1999). Detailed studies of dis-
tribution and expression of SK2 channels in rat and mouse
brain by immunohistochemistry detected a distinct pattern
of SK2-LI in these regions (Sailer et al. 2002, 2004). In
Fig. 2 Distinct localization of SK2 proteins in human brain detected
with Anti-NSK2. In hippocampus, SK2-LI was most prominent in the
stratum oriens and pyramidale of the CA1–CA2 region and in stratum
moleculare (a). In the amygdala, SK2 protein was mainly detected in
the basolateral nuclei (b). In neocortex, SK2-LI was mainly detected
in pyramidal cells of layer V (c). The immunostaining signal was
blocked by pre-incubation with the corresponding peptide (inlay in a).
sr stratum radiatum, sp stratum pyramidale, so stratum oriens, slm
stratum lacunosum moleculare, sm stratum moleculare, gl granule cell
layer, BLA basolateral amygdala, I–VI layers of the neocortex. Scale
bars 500 lm in a, b; 250 lm in c
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neocortex, highest levels were detected in pyramidal layer
V, while in the amygdala, highest levels were detected in
basolateral nuclei (Sailer et al. 2002, 2004). In hippocam-
pal regions of mouse and rat brain, highest levels of SK2-
LI were detected in strata oriens (especially in the layer of
the proximal dendrites of pyramidal cells) and radiatum of
CA1–CA2. Also, strong and homogeneous labeling was
observed in the subiculum. Medium levels of SK2-LI were
found in the stratum lacunosum moleculare, while the
stratum pyramidale exposed only moderate levels of SK2-
LI (Sailer et al. 2002, 2004). These findings were supported
by recent studies performed at electron microscopic level
in mouse brain (Ballesteros-Merino et al. 2012), and
through whole-cell voltage-clamp and current-clamp
recordings in rat CA1 pyramidal cells (Chen et al. 2014). In
human hippocampal regions, highest expression levels of
SK2-LI were detected in strata oriens and radiatum of area
CA1 and CA2. Despite the fact that the overall staining
pattern of Anti-CSK2 and Anti-NSK2 in human hip-
pocampus is similar, subtle differences in SK2-LI of
pyramidal cells and granule cells are obvious. When anti-
bodies were diluted to lower concentrations, SK2-LI
detected with Anti-NSK2 was restricted to strata oriens and
radiatum of CA1/CA2 subfields and the molecular layer,
while immunoreactivity in pyramidal cells and granule
cells was low. On the contrary, low concentrations of Anti-
CSK2 detected SK2-LI mainly in pyramidal neurons and
granule cells (data not shown). The most likely explanation
for this discrepancy is that Anti-NSK2 is not capable to
detect SK2-hib. Since Anti-NSK2 detected more SK2-LI in
laminar structures, while Anti-CSK2 detected prominent
SK2-LI in pyramidal cells, this could reflect SK2-hib
expression in cell soma and cellular membranes.
Conclusion
The aim of the current work was to establish a distri-
bution profile of SK2-LI in parts of the human brain
important for memory formation as the hippocampal
formation, the neocortex and the amygdala. This is the
first evidence for the expression of all four SK2 isoforms
in human brain. The work by Stocker et al. (1999)
showed that it is unlikely that homomeric SK2 channels
underlie the afterpotential, as it is blocked by apamin
with a sensitivity that suggests heteromeric channels.
Electrophysiological studies in mouse brain showed the
formation of functional homomeric and heteromeric SK2
channels by assembly of SK2-std and SK2-long (Allen
et al. 2011b), but not for SK2-ssv (Murthy et al. 2008).
To our knowledge, there is no electrophysiological data
available for SK2-hib.
Fig. 3 Comparison of SK2-LI obtained with antibodies directed
against the C-terminal and the N-terminal region of the SK2 peptide.
Adjacent sections of SK2-LI detected with ANTI-CSK2 (a, c, e, g and
i) and Anti-NSK2 (b, d, f, h and j). In hippocampus, SK2-LI was
detected in molecular layer and in strata oriens and radiatum of CA1
(a, b). In granule cell layer, SK2-LI could be detected mainly in the
plasma membrane (c, d). In pyramidal layer, somata and apical
dendrites showed expression of SK2 peptide (e, f). In the amygdala,
SK2-LI in basolateral nuclei was detected in cell somas (g, h). In the
neocortex, SK2-LI detected with the N-terminal antibody showed
only moderate immunoreactivity in cells of layer V (j), while SK2-LI
detected with Anti-CSK2 was found as well in layer IV and VI (i). sr
stratum radiatum, sp stratum pyramidale, so stratum oriens, slm
stratum lacunosum moleculare, ml molecular layer, gl granule cell
layer, pl pleomorphic cell layer, BLA basolateral amygdala, IV, V, VI
layers of the cortex, Scale bar 200 lm in a, b; 30 lm in c–f; 60 lm in
g–j
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